Patent directory · USPTO A61K / A61P
Patents matching “SION”
1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12098215
Fusion protein construct
granted -
US 12090227
Method to improve the encapsulation efficiency and physicochemical stability of ginsenosides Rg3 and CK nano-emulsion
granted -
US 12090145
Combination therapy for treating or preventing depression or other mood diseases
granted -
US 12091440
IL2 and peptide-MHC complex fusion proteins and methods of use thereof
granted -
US 12091675
Gene therapy of hemophilia a using viral vectors encoding recombinant FVIII variants with increased expression
granted -
US 12077772
Transgene cassettes, AAV vectors and AAV viral vectors for the expression of human codon-optimized SLC6A1
granted -
US 12076397
Emulsion adjuvant for intramuscular, intradermal and subcutaneous administration
granted -
US 12077563
Prefusion-stabilized hMPV F proteins
granted -
US 12077502
Formulations of T-type calcium channel modulators and methods of use thereof
granted -
US 12071516
Polymeric stabilizing formulations
granted -
US 12060566
Self-inactivating lentiviral vector comprising a FOXP3 expression cassette
granted -
US 12054501
Compositions and methods for inhibiting arginase activity
granted -
US 12054718
RNAi agents for inhibiting expression of PNPLA3, pharmaceutical compositions thereof, and methods of use
granted -
US 12053519
HIV-1 Env fusion peptide nanoparticle carrier conjugates and their use
granted -
US 12043831
Modulation of alpha synuclein expression
granted -
US 12042510
Modulators of IRF4 expression
granted -
US 12037410
Methods and compositions for targeting Treg cells
granted -
US 12031157
Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 12029577
Neuromodulation to target glucose transporter and/or incretin pathways
granted -
US 12031133
GNAQ targeted dsRNA compositions and methods for inhibiting expression
granted -
US 12030958
Compositions and methods of use of alpha-1 antitrypsin fusion polypeptides
granted -
US 12024718
Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 12016932
Gene editing for hemophilia A with improved factor VIII expression
granted -
US 2024197727
SOLID DISPERSIONS COMPRISING AMORPHOUS PIMOBENDAN AND ONE OR MORE STABILIZING POLYMERS
granted